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Encoding for several memory types requires neural changes and the activity of distinct regions across the brain. These areas receive
broad projections originating in nuclei located in the brainstem which are capable of modulating the activity of a particular
area. The histaminergic system is one of the major modulatory systems, and it regulates basic homeostatic and higher functions
including arousal, circadian, and feeding rhythms, and cognition. There is now evidence that histamine can modulate learning in
diﬀerent types of behavioral tasks, but the exact course of modulation and its mechanisms are controversial. In the present paper
we review the involvement of the histaminergic system and the eﬀects histaminergic receptor agonists/antagonists have on the
performance of tasks associated with the main memory types as well as evidence provided by studies with knockout models. Thus,
we aim to summarize the possible eﬀects histamine has on modulation of circuits involved in memory formation.
1.Introduction
The initial step in the formation of a new memory is the
acquisition of information related to that particular trace,
coming from external stimuli (sensory input arising from
subject-environment interaction) or from internal repre-
sentations (cognition and emotion) [1–5]. This acquisition
phase is referred to as learning. After the subject learns,
information must be stored either for a brief or a long
period of time. While that information remains stored, it
can be accessed by the process known as retrieval. Memory,
thus comprises the processes responsible for retention and
retrieval of learned experience [5, 6]. Short-term memory
retention (deﬁned in minutes or hours) may be converted to
long-termretention(deﬁnedindays,weeks,orevenyears)by
aspeciﬁcsequenceofeventscalledconsolidationwhichstarts
immediately after the acquisition phase [1, 3–7]. Finally,
as time passes, even the most consolidated memories may
disappear, a process called forgetting [8].
Not all information reaching the central nervous system
(CNS) is stored. Most inputs do not pass the acquisition
phase, because they are ﬁltered out by attentional and
emotional mechanisms [1, 7–9]. Only a few inputs selected
for acquisition and retention are consolidated in long-
term memories, and many of the latter are forgotten. Only
memories relevant for cognition, emotionally more salient,
more focused by attention or associated to stronger sensory
input willactuallypersist. Inthis context, forgetting may also
be seen as a ﬁlter, since it only aﬀects memories previously
selected to persist by emotional and attentional ﬁlters. Thus,
the brain systems responsible for learning and memory have
a mechanism for preventing information overload [5, 8, 10].
Most CNS functions may be modulated so as to be
activated or deactivated, accelerated or slowed down, and
enhanced or diminished, but the exact course of action is
determined by the needs relevant for a particular moment
[10]. Memory is no exception to this rule and can thus be
modulated by experiences occurring about the time when2 Neural Plasticity
it is learned, consolidated, or retrieved [7]. The major
modulatory systems are composed of diﬀusely spread ﬁber
bundles that reach a broad area in the CNS. These ﬁbers
originate from nuclei in the brainstem, diencephalon, and
basal forebrain. They act by means of several neurotrans-
mitters, including acetylcholine, noradrenaline, dopamine,
serotonin, and histamine [7, 11–13].
Histamine is involved in the control of several behavioral
and neurobiological functions such as the sleep-wake cycle,
water intake, motor activity, and nociception [13, 14]. His-
tamine is known to decrease calcium-dependent membrane
conductance in the hippocampus [15], to increase neuronal
excitability [16], and control high-frequency oscillations [17,
18], and it also facilitates NMDA glutamatergic receptor-
mediated responses [19]. However, the part histaminergic
circuits play in mnemonic systems is complex. Histamine
seems to have diﬀerent eﬀects in distinct brain regions
and may have modulatory eﬀects that diﬀer according to
memory type. The evidence indicating the exact role of
histamine in learning processes and memory consolidation
is still controversial. In particular, the action of the receptor
subtypes and how they aﬀect key circuits related to a speciﬁc
memory system is not well understood.
Here, we will ﬁrst present a short review of the anatomy,
biochemistry, and physiology of the histaminergic system
and synaptic plasticity. Then, we will summarize pharmaco-
logical studies and other evidence that aims to identify the
possible role of histamine in the modulation of brain regions
pertaining to circuits involved in processing several types of
memories.
2. Anatomy of the HistaminergicSystem
Here, we highlight the key aspects of the anatomy of
the histaminergic system. For more details, the reader is
encouraged to see [20–23]. Figure 1 presents the main
projections of histaminergic neurons in the rat brain.
In vertebrates, neurons that produce histamine are
located in the tuberomammillary nucleus (TMN), which
is part of the posterior hypothalamus [14, 21]. The main
aﬀerent projections to the TMN come from the infralimbic
cortex, lateral septum, preoptical nucleus, and neuronal
groups in the brainstem [23, 24].
The ﬁnal target of histaminergic ﬁbers varies slightly
across species, but they reach almost the entire CNS. There
are moderate-to-dense histaminergic nerve terminals in
the cerebral cortex, amygdala, substantia nigra, striatum,
hippocampus, and thalamus [20–22]. As a result of these
broadprojections,histaminereceptorsaredistributedwidely
in the CNS.
3.HistamineMetabolismand
Neuronal Turnover
In neurons, histamine is synthesized from the amino acid L-
histidine,whichistransportedfromtheextracellularintothe
intracellular space by the L-aminoacid transporter located
in the cell membrane. Once in the cytoplasm, L-histidine is
decarboxylated by the enzyme histidine decarboxylase, with
histamine as the end product of the reaction. This newly
synthesized histamine is transported into synaptic vesicles by
the vesicular monoamine transporter 2 (VMAT-2). Action
potentials that reach the axonal endings trigger the fusion
of the vesicles with the presynaptic membrane, releasing
histamine in the synaptic cleft [13, 14].
In the extracellular space, histamine is methylated by
enzyme histamine methyltransferase in the postsynaptic
membrane and glial cells. The end product of this methy-
lation reaction is telemethylhistamine, a metabolite that has
no histaminergic activity. Since this amine does not have a
high-aﬃnity reuptake mechanism, methylation is the main
mechanism for inactivation of released histamine [13, 14].
The turnover rate of neuronal histamine is high, and its
half-life (which is about 30 minutes in basal conditions) can
changerapidlyinresponsetoneuronalactivity.Turnoverrate
increases when subjects experience stressful events such as
forced immobilization or a foot shock [21].
The control of histamine synthesis and release is medi-
ated by H3 type autoreceptors that are located in the
soma and axonal endings of the histaminergic neurons
[25]. Histamine release may also be regulated by inhibitory
M1 muscarinic receptors [25–27], α2 adrenergic receptors
[26, 28, 29], 5-HT1A serotonergic receptors [30], κ opioid
receptors [26,31]andgalaninreceptors[26],orfacilitatoryμ
opioid receptors [32]. In vivo experiments have shown nitric
oxide to inhibit histamine release in the hypothalamus [33].
The circadian rhythm of histamine release coincides
with changes in the ﬁring pattern of histaminergic neurons
occurring during the sleep-wake cycle [14, 33]. TMN his-
taminergic neurons resemble a pacemaker activity pattern:
they ﬁre action potentials at a slow frequency (<3Hz).
Electrophysiological recordings of these neurons in cats
showed their activity increased during wake time, and
decreased or was completely absent during sleep [14, 34, 35].
However, histamine release can follow a faster ultradian
rhythm correlated to the delta and theta bands in electroen-
cephalographic recordings [14, 36].
4.HistaminergicReceptors
In the nervous system of vertebrates most histaminergic
axonal endings (varicosities) are not in close contact with
postsynaptic sites [37]. This causes histamine to have a
diﬀuse action pattern which is similar to other biogenic
amines [14].
To date, histamine eﬀects are known to be mediated by
four distinct types of receptors (H1 to H4) coupled to G
proteins and several associated second messengers. Figure 1
shows their distribution across the rat brain. H1, H2, and
H3 receptor types are expressed mainly in nervous tissues,
and H4 type in peripheral tissues like bone marrow and
leukocytes. Generally, H1 and H2 receptors excite or poten-
tiate excitatory impulses [14, 37–39], while H3 activation
mediates autoinhibition of TMN neurons and inhibits the
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Figure 1: Main histaminergic projections and histamine receptor distribution in the rat brain. The shapes mark the main sites where each
receptorsubtypeislocated.Inareasthathavemorethanonereceptorsubtype,theshapewiththebiggestsizeindicateswhichispredominant.
Acc: nucleus accumbens; Amy: amygdala, Hipot: hypothalamus, Str: striatum, SN: substantia nigra.
such as glutamate, acetylcholine, and noradrenaline [14, 40,
41].
The H1 receptor is a protein with 486–491 amino acid
residues and is encoded by a gene without introns [14, 42].
It is coupled to the activation of the Gq/11 protein, which
activates phospholipase C (PLC) [13]. Thus, the intracellular
eﬀects of H1 receptor activation are mediated by lipid
second messengers related to intracellular calcium stores.
Downstream signaling pathways are involved in synaptic
plasticity. This receptor has been identiﬁed in the cortex,
hippocampus, amygdala, hypothalamus, thalamus, striatum,
and cerebellum [43].
The H2 receptor is also encoded by a gene without
introns and is a protein with 358-359 amino acid residues
[14, 44, 45]. It is coupled to the Gs protein, which stimulates
adenylate cyclase and, subsequently, protein kinase A (PKA)
[13]. This receptor is mainly found in the basal ganglia,
amygdala, hippocampus, and cortex. H2 receptor activation
also provokes downstream signaling cascades, which are able
to mediate functional and structural changes in synapses, as
in the case of the PKA pathway [46].
The H3 receptor has several isoforms [47, 48] and is
a protein with 326–445 amino acid residues. The isoforms
originate in the expression of a single gene through the
alternative processing of mRNA (splicing). The intracellular
eﬀects of this receptor start with the activation of the
inhibitory Gi/Go protein and the subsequent inhibition
of adenylate cyclase [13]. The H3 receptor is found in
histaminergic neurons as an autoreceptor, and its intra-
cellular inhibitory actions control histamine synthesis and
release [25, 49–51]. This receptor subtype can also regulate
the release of acetylcholine, dopamine, GABA, glutamate,
noradrenaline, 5-HT, and tachykinins by means of this
presynaptic mechanism [14, 40, 41, 52–54]. The H3 receptor
also participates in the activation of the MAPK signaling
pathway [48]. Its mRNA is found in several types of neurons
and has been identiﬁed in rats mainly the cerebral cortex,
the hippocampus, tenia tecta, nucleus accumbens, caudate
putamen, thalamus, amygdala, cerebellum, vestibular nuclei,
and some hypothalamic nuclei [55]. The actual location
of the receptor protein may be very distant from the cell
bodies that express mRNA, and the major brain sites where
binding activity takes place are the cerebral cortex, amygdala,
nucleus accumbens, caudate putamen, globus pallidus, and
substantia nigra [55].
5.HistamineandSynapticPlasticity
Long-term potentiation (LTP) is considered the main
demonstration of synaptic plasticity. It was ﬁrst described
in the hippocampus, a brain region directly involved in the
formation of several memory types [10, 56–58]. It consists
of the lasting enhancement of the postsynaptic response
following a high-frequency aﬀerent stimulation. This is seen
as an increase in the excitatory postsynaptic potential evoked
by a single stimulation pulse when compared to the response
evoked before the high-frequency stimulation [57]. There
is evidence that this form of synaptic enhancement is also
present in other regions of the cerebral cortex, especially
during early developmental stages [59]. LTP has several
characteristics that make it a strong candidate for the cellular
mechanism responsible for long-term memory storage (see
[59] for a more detailed review about this matter).
Among the several mechanisms that are jointly respon-
sible for LTP, the activation of the glutamatergic NMDA
receptor plays a central role in both the induction and4 Neural Plasticity
maintenance of most LTP types [59]. The calcium inﬂux in
the postsynaptic dendritic spine leads to the activation of
several signaling cascades, notably the calcium/calmodulin-
dependent protein kinase II (CaMKII), the protein kinase
A (PKA), the protein kinase C (PKC), and the mitogen-
activated protein kinase (MAPK). Their ﬁnal course of
action is the activation of transcription factors like CREB,
which control the synthesis of the proteins required for the
maintenance of the increased postsynaptic response [59–62].
This process may be modulated by histamine [63].
LTP was facilitated by histamine in the CA1 area of rat
hippocampal slices, since it could be induced with a weak
tetanic stimulation when histamine was added to the bath,
and this eﬀect persisted even in the presence of H1 and
H2 receptor antagonists. It was then demonstrated that
histamine or its major metabolite, 1-methylhistamine [64],
may enhance NMDA induced response and subsequently
hippocampal LTP by means of direct channel activation by
binding to the polyamine site [14, 65, 66].
Regarding the eﬀects of histamine on LTP, H1 receptor
activation has been shown to reduce the blockage of the
NMDA receptor channel mediated by the ion Mg2+,b y
activating PKC, which leads to increased activation of the
glutamatergic receptor [67]. In addition, as already pointed
out, histamine can also directly activate the NMDA receptor
by binding to the polyamine modulatory site present in this
receptor [19, 68]. Binding is pH sensitive and is restricted
to the NR1/NR2B subunits of the NMDA receptor [64].
Furthermore, H1 receptor activation leads to the synthesis of
postsynaptic retrograde messengers, such as nitric oxide and
arachidonic acid, which might be responsible for presynaptic
modiﬁcations that occur after LTP induction [14, 41]. As an
example of the possible involvement of this receptor in LTP,
H1 receptor knockout mice showed impaired LTP induction
in the CA1 region of the hippocampus [68].
As mentioned above, the H2 receptor is a potent stimula-
torofthecAMPsignaling pathway,whichisnecessaryforthe
late phase of NMDA receptor-dependent LTP [69]a n df o r
LTP expression in giant hippocampal mossy ﬁber synapses
[70]. H2 receptors can also increase ionic currents generated
by the activation of the NMDA receptor, through blockage of
calcium-dependentpotassiumchannels[71],andpossiblyby
mediating the phosphorylation of the NMDA receptor itself
by PKA [72]. LTP induction in the hippocampus was also
impaired in H2 receptor knockout mice [68].
The eﬀects might change across diﬀerent brain regions.
H3 receptors can reduce the release of several neurotrans-
mitters, including glutamate, which might aﬀect synaptic
plasticity in hippocampus and striatum [40, 73]. In dentate
gyrus, for instance, H3 receptor activation hinders synaptic
transmission and reduces paired-pulsed facilitation, which
is a short-term form of synaptic plasticity [74]. In the CA3
region of the hippocampus, histamine promotes synchro-
nized bursts of action potentials [75], an activity pattern that
is known to be a physiological stimulus for the occurrence
o fL T Pi nt h eC A 1r e g i o n[ 76]. In the CA1 region, when
Ca2+ levels are low and Mg2+ levels are high, histamine
causes a lasting potentiation of neuronal excitability, which
is mediated mainly by H2 receptor activation and the PKA
signaling pathway, with H1 and NMDA receptors having a
modulatory role in that downstream cascade.
Thus, histamine can enhance LTP through at least three
diﬀerent mechanisms: H1 receptors favor LTP by increasing
intracellular levels of Ca2+ and subsequent PKC activation,
both required for LTP induction, the eﬀects of the H2
receptors are mediated by cAMP/PKA signaling pathway
activation, which is involved in the maintenance of LTP,
and ﬁnally, the NMDA receptor can be directly activated by
histaminebindingtothepolyaminesite,whichcanmodulate
both LTP induction and maintenance [14, 65, 66].
6. Histamineand Memory
6.1. Systemic Administration of Histamine and Memory Per-
formance. The ﬁrst approach to elucidate the possible role
of histamine on memory systems consisted in the systemic
administration of several drugs that mimic or counteract
the action of histamine and its receptors. These studies are
summarized in Table 1.
6.1.1. Memory Impairment. There is a considerable body
of work on the role of histamine in models of memory
impairment induced by systemic administration of antago-
nists of the neurotransmitters acetylcholine and glutamate,
most notably using the muscarinic receptor antagonist
scopolamineortheNMDAreceptorantagonistMK-801.The
reversal of memory deﬁcit produced by systemic administra-
tion of histamine in these models of memory impairment
was evaluated in several behavioral tasks (see Table 1 for
references).
The evidence suggests that this reversal comes about
as a result of the interplay between the histaminergic and
cholinergic systems. It is known that both cholinergic and
gabaergic projections of the septum to the hippocampus are
important in generating hippocampal theta rhythm [100,
101]. It has been demonstrated that histamine can activate
gabaergic neurons in the septohippocampal pathway, by
binding to the H1 and H2 receptors [102]. Furthermore,
electrical stimulation of TMN has been shown to increase
acetylcholine (ACh) release in the hippocampus [103], and
intraseptal infusions of histamine also enhance hippocampal
ACh release [104]. Thus, histamine can regulate the hip-
pocampal electrical activity and induce ACh release in the
hippocampus in physiological states. The improvement seen
in scopolamine-induced deﬁcits might be mediated by such
modulation of the septohippocampal pathway.
6.1.2. Physiological Context. Systemic studies that investigate
the impact histamine has on memory in a physiological
contextshowtheeﬀecttodiﬀerwithrespecttothebehavioral
paradigm,andthusthememorytype,andmoststudies,deals
with the direct manipulation of a single histamine receptor
(Table 1).
In aversive tasks like inhibitory avoidance, the systemic
administration of an H3 receptor antagonist improves
performance (see Table 1 for references). These studies have
used ligands with varying degrees of potency, bioavailability,Neural Plasticity 5
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and aﬃnity for studying species receptor [105]. While
some studies used classical ligands now classiﬁed as inverse
agonists (like thioperamide and clobenpropit, which have
nonspeciﬁc actions, notably on the 5-HT3 serotonergic
receptor and α2C adrenergic receptor [105]), studies employ-
ingligandswithadiﬀerentchemicalstructureandwithmore
selectivity and aﬃnity to the H3 receptor showed similar
memory enhancing eﬀects. By contrast, the administration
of an H3 receptor agonist impairs performance [96], and
both non-speciﬁc ligands like RAMH (also active on nora-
drenergic receptors) and imetit (also active on serotonergic
receptors) and the more selective ligand immepip produced
similar memory impairment eﬀects. Together, these data
highlight the possible role of H3-mediated modulation on
aversive learning.
On the other hand, the administration of an H1 receptor
antagonist has produced diﬀerent results for aversive mem-
ory tasks [97, 98]. It must be noted, though, that there is an
age diﬀerence in the experimental subjects. The expression
pattern of the histamine receptor subtypes alters with age
in rodents. Since the H1 receptor has the most widespread
changes in density [106], this might account for the opposite
eﬀect. Finally, the alkylamine chlorpheniramine used in the
study also has nonspeciﬁc actions, notably the inhibition
of noradrenaline and serotonin reuptake, which could also
account for the reported eﬀects [107, 108]. Although there
a r es o m ed i ﬀerences between passive and active avoidance
tasks regarding learning (active avoidance involves multitrial
learning task, while passive avoidance is singletrial, the latter
being more suitable to pharmacologically dissect the role
of certain receptors or signaling pathways), the only study
that evaluated ﬁrst generation and the more selective second
generation H1 blockers using active avoidance showed that
those nonspeciﬁc eﬀects might indeed play a role in the
evaluationoftheactionofH1receptorsonaversivememory:
although all the compounds impaired learning, the extent
of the impairment seems to be greater for the nonspeciﬁc
compounds [98].
The results of systemic studies are contradictory regard-
ingtheeﬀectthehistaminergicsystemhasonspatialmemory
tasks such as the water maze (Table 1). The administration
of a histamine precursor did not produce any eﬀects, while
the administration of an H3 receptor agonist improved
performance [99]. This may be explained by the fact that
the H3 receptor is also found on neurons that release other
neurotransmitters, thus improvement could be mediated by
the regulation of other systems involved in spatial learning,
such as the dopaminergic system [109, 110], and not only
by increasing the synaptic availability of histamine. Another
explanation would be that the H3 agonist RAMH ligand is
not speciﬁc to histamine and may also have aﬃnity for other
aminergic receptors [105].
6.2. Transgenic Models. Recent studies have used transgenic
models to try to identify the role of histamine and each
receptor subtype on memory processes. These studies are
summarized in Table 3.
There is evidence that the lack of the histamine decar-
boxylase enzyme produces changes in the performance of
some memory tasks although the course might also diﬀer
with respect to memory type. In the water maze task, spatial
memory has been shown to be both hindered and improved
in histamine decarboxylase knockout mice (Hdc −/− mice)
[111, 112] though these diﬀerences may be inﬂuenced by the
gender base used in the models. Thus, although the evidence
provided by the transgenic models shows that histamine
participates in the modulation of at least some memory
systems, the exact course of its actions remains unclear.
Knockout models for H1 and H2 receptors, on the other
hand, have shed more light on the physiological role of
histamine in learning. They act negatively on the learning of
aversive tasks but facilitate spatial and discriminative ones.
Interestingly, the only study that addresses the role of the
three histamine receptors in a Barnes-maze task showed that
the lack of an H3 receptor improves memory. The absence
of presynaptic autoinhibitory receptors might potentiate the
action of histamine in postsynaptic H1 and H2 receptors,
which also modulated the memory associated with this
particular task (see Table 3 for references).
An important factor in the interpretation of studies with
knockout models is that the inactivation of the genes of
interest is not restricted to an area or speciﬁc part of the
circuits involved, and thus, these eﬀects are likely to reﬂect
theoverallactionofhistamineoritsreceptors.Maybestudies
using temporally and spatially restricted knockout models
could clarify the role of histamine in each brain site leading
toabetterunderstandingregardinghowitmodulatescircuits
responsible for processing diﬀerent memory types.
6.3. Intracerebroventricular (ICV) Administration of His-
tamine and Memory Performance. The administration of
histamine or its receptor agonists/antagonists in the ventric-
ular system is a more convenient way to study the role of
histamine in the CNS than peripheral administration, since
some ligands might be more prone to cross the blood-brain
barrier, and there is less potential for peripheral side eﬀects.
In Table 3, we have summarized the studies that employ
this delivery route in attempting to address the role of the
histaminergic system.
Histamine had facilitatory actions in social learning,
since its ICV infusion improved, while the inhibition of
its synthesis hindered the performance. Also, pharmacolog-
ical stimulation with the potent and selective H3 agonist
immepip led to impaired performance in learning the task,
while the use of the inverse agonist thioperamide facilitated
it. The role of the other receptor types is not addressed, and
thus, the H3 receptor response and histamine eﬀect might be
due to the regulation of other neurotransmitter systems.
Conversely, the ﬁndings of studies that used tasks
based on learning an aversive memory are controversial.
Studies that employed a passive avoidance task showed
either improvement or impairment of the task following
ICV administration of histamine [120–124], but the doses
administered varied: 1–10ng/rat of histamine improved
performance, while 20μg/rat impaired it. EC50 of the H3Neural Plasticity 7
Table 2: Knockout mice models and memory performance.
Behavioral task Knockout type Eﬀect on memory Reference(s)
Water maze∗ Hdc −/−↓ [111]
Water maze Hdc −/−↑ [112]
Object recognition∗ Hdc −/− Unaﬀected [111]
Nonreinforced episodic object
memory Hdc −/−↓ [112]
Contextual fear conditioning Hdc −/−↑ [113]
One-trial passive avoidance Hdc −/−↑ [111]
Open ﬁeld (habituation) Hdc −/− Unaﬀected [114]
Inhibitory avoidance KO H1−/− Unaﬀected [115]
Conditioned place preference KO H1−/−↓ [116]
Radial-maze task KO H1−/−↓ [117]
Auditory and contextual fear
conditioning KO H1−/−↑ [68]
Auditory and contextual fear
conditioning KO H2−/−↑ [68]
Object recognition KO H1−/−↓ [68]
Object recognition KO H2−/−↓ [68]
Barnes maze KO H1−/−↓ [68]
Barnes maze KO H2−/−↓ [68]
Barnes maze KO H3−/−↑ [118]
Motoric long-term memory KO H1−/−↓ [119]
Episodic and procedural
memory KO H1−/−↓ [119]
∗This work was done using female mice.
Hdc: histidine decarboxylase.
H1, H2, H3: histaminergic receptor type.
receptors are at least one order of magnitude lower than
H1 and H2 receptors [13], and thus, the low concentration
might be causing a mainly H3-based response, thus acting
negatively on the histaminergic system, which would explain
thereportedimprovementinaversivememory.SinceH1and
H2 receptor blockage also improved the memory for the
same task, this would corroborate the inhibitory actions of
histamine in aversive learning [122–124].
The ﬁndings of two studies employing the active avoid-
ance paradigm were also contradictory [127, 135], but the
study that showed memory improvement was found with
the use of aged rats, which might account for the reported
contradictory eﬀects. Finally, there is controversy regarding
the role of the H1 receptor in the active avoidance task,
since it was shown that this could either inhibit or facilitate
performance in active avoidance tasks [127, 132].
The ICV administration of compounds that act on
the histaminergic system is less studied in spatial memory
and object recognition or discriminative memory types.
Histamine reverses the impairment induced by NMDA
antagonists in a radial maze task [130]. The activation of
both glycine and polyamine sites can act synergistically
in memory function [136], and thus, histamine might
compensate the deﬁcit through direct action on the NMDA
receptor. However, in a physiological context, the blockage of
histamine synthesis [131] or lack of the gene that encodes
the H1 receptor impaired performance in the radial maze
[117], while H1 receptor inactivation improved the memory
in the water-maze task [134]. Methodological particularities
of these tasks that rely on spatial memory might explain
this diﬀerential eﬀect. H1 receptor activation facilitated
learning the object recognition task, and this is in agreement
with studies that used knockout models (Table 3). The
brain areas involved are slightly diﬀerent for spatial and
discriminative tasks, with spatial memory depending mainly
on the hippocampus, while discriminative memory relies on
other cortical areas, such as the perirhinal cortex [137–139].
Thus, the diﬀerent roles the H1 receptor seems to have in
spatial and recognition memory might rely on those distinct
anatomic requirements, since the density of H1 receptors is
diﬀerent in the cortex and the hippocampus.
6.4. Administration of Histamine into the Hippocampus and
Memory Performance. The hippocampal formation is com-
posed of three subregions: the Ammon’s horn, the dentate
gyrus, and the subiculum. The Ammon’s horn is further
divided into the subﬁelds CA1–CA4. These subregions are
connected to form a closed-loop circuit with the adjacent
entorhinal cortex (EC). Neurons from the layer II of the
EC project to the dentate gyrus and the CA3 subﬁeld,
while neurons from layer III project directly to CA1. The8 Neural Plasticity
Table 3: Intracerebroventricular administration of drugs that act on the histaminergic system and memory performance.
Species Behavioral task Histaminergic modulator
Lesion or pharmacological
induced memory
impairment
Eﬀect on
memory Reference(s)
Rat Passive avoidance Histamine ↑ [120, 121]
Rat Passive avoidance Histamine ↓ [122–124]
Mouse Passive avoidance Histamine Lithium (i.p.) ↑ [125]
Rat Active avoidance Histamine ↑ [126]
Rat Active avoidance Histamine ↓ [127]
Rat Active avoidance Histamine Bilateral hippocampectomy
(dorsal hippocampus)
↑ [128]
Rat Active avoidance Histamine alpha-FMH (i.p.) ↑ [126]
Rat Habituation in open ﬁeld Histamine ↑ [121]
Rat Social memory Histamine ↑ [129]
Rat Social memory Histidine ↑ [129]
Rat Social memory alpha-FMH ↓ [129]
Rat Radial maze Histamine
N-methyl- d-aspartate
(NMDA) receptor glycine
site antagonist
(7-chlorokynurenic acid)
i.c.v
↑ [130]
Rat Radial maze alpha-FMH ↓ [131]
Rat Passive avoidance H1 receptor antagonist
(chlorpheniramine)
↑ [122]
Rat Passive avoidance H1 receptor antagonist
(pyrilamine )
↑ [124]
Rat Passive avoidance H2 receptor antagonist
(cimetidine)
↑ [123, 124]
Mouse Passive avoidance H2 receptor agonist
(4-methylhistamine)
↓ [90]
Rat Active avoidance
H1 receptor agonist
(2-methylhistamine and
2-thiazolylethylamine)
↓ [127]
Rat Step-through active
avoidance
H1 receptor agonist
(2-methylhistamine)
↑ [132]
Rat Step-through active
avoidance
H1 receptor antagonist
(pyrilamine or
diphenhydramine)
↓ [132]
Rat Social memory H3 receptor agonist
(immepip)
↓ [129]
Rat Social memory H3 receptor antagonist
(thioperamide)
↑ [129]
Rat Object recognition
H1 receptor agonist
[2-(3-(triﬂuoromethyl)-
phenyl)histamine]
↑ [133]
Rat Water maze H1 receptor antagonist
(chlorpheniramine)
↑ [134]
alpha-FMH: alpha-ﬂuoromethylhistidine (inhibitor of histamine decarboxylase)
i.p. intraperitoneal
i.c.v intracerebroventricular.
projections from the EC are known as the perforant pathway.
Neurons from the DG project to the CA3 subﬁeld, through
the mossy ﬁber pathway. CA3 neurons make synapse with
neurons from the CA1 region through the Schaﬀer collateral
pathway. Finally, to close the loop, the CA1 region neurons
project to the layer V of the entorhinal cortex [148, 149].
The superﬁcial entorhinal layers receive input from other
cortical areas and the olfactory bulb. The CA1 area is
the main output of the hippocampus, which is directed
mainly to the EC, which act as a hub to other cortical
areas. The hippocampus can also project to subcortical
areas, mainly through subiculum. Among the subcorticalNeural Plasticity 9
Table 4: Intrahippocampal administration of drugs that act on the histaminergic system and memory performance.
Species Hippocampal site Behavioral task Histaminergic modulator Eﬀect on memory Reference(s)
Rat1 Dorsal Inhibitory avoidance Histamine ↑ [140]
Rat2 Ventral One-way active avoidance Histamine ↓ [141–143]
Rat Dorsal One-way active avoidance Histamine Unaﬀected [143]
Rat2,3 Dorsal Eight-arm radial maze Histamine ↑ [78]
Rat4 Intrahippocampal Radial maze Histamine ↑ [80]
Rat Dorsal Inhibitory avoidance H2 receptor agonist
(dimaprit)
↑ [140]
Rat5 Ventral Active avoidance H3 receptor antagonist
(clobenpropit)
↑ [144]
Rat Dorsal Contextual fear
conditioning
H2 receptor agonist
(amthamine)
↑ [145]
Rat Dorsal Contextual fear
conditioning
H3 receptor agonist
(RAMH)
↑ [145]
Rat3 Dorsal Eight-arm radial maze H3 receptor antagonist
(clobenpropit)
↑ [146]
Rat Dorsal Three-panel runway H1 receptor antagonist
(pyrilamine)
↓ [147]
RAMH: (R)-(−)-alpha-methylhistamine
1Eﬀect reverted with concomitant administration of the H2 receptor antagonist ranitidine
2Eﬀect reverted with concomitant administration of the H1 receptor antagonist pyrilamine
3Impairment induced using intrahippocampal injection of MK-801
4Impairment induced using intraseptal injection of muscimol
5Impairment induced using intrahippocampal injection of scopolamine.
Table 5: Administration of drugs that act on the histaminergic system into the amygdala and memory performance.
Species Amygdala site Behavioral task Histaminergic modulator Eﬀect on
memory Reference(s)
Rat Basolateral Active avoidance Histamine ↓ [144]
Rat Basolateral Contextual fear
conditioning
H3 receptor antagonists
(ciproxifan, clobenpropit
and thioperamide)
↓ [154]
Rat Basolateral Contextual fear
conditioning
H3 receptor agonists
(RAMH or Immepip)
↑ [144, 155]
Rat Basolateral Contextual fear
conditioning
H3 receptor agonist
(proxifan)
↑ [156]
RAMH: (R)-(−)-alpha-methylhistamine.
input to the hippocampus are projections from the septum,
amygdala, thalamic nuclei, diagonal band of Broca, the
basal nucleus of Meynert, the tuberomammillary nucleus,
the ventral tegmental area, the raphe nuclei, and the locus
coeruleus. Finally, the connectivity of the hippocampus to
other structures diﬀe r sw i t hr e s p e c tt oi t sd o r s o v e n t r a la x i s
[148–150].
The hippocampus is central in spatial memory tasks
[56], and the NMDA receptor plays an important role in
this type of learning [151]. The impairment in radial maze
learning induced by the NMDA receptor antagonist MK-801
could be reversed by the direct administration of histamine
in the hippocampus [78]. Since the blockage of the H3
receptor in this structure had a similar eﬀect and the reversal
was hindered by the administration of an H1 receptor
antagonist [78], the observed improvement might be due
to the increased synaptic availability of histamine and its
binding to postsynaptic H1 receptors [78]. The modulation
of the excitability of hippocampal cells through the H1 and
H2 receptors [13] and the direct activation of the NMDA
receptor through the polyamine site [65, 66] are possible
mechanisms to mediate the observed eﬀects.
The inhibition of the septum or the administration of
scopolamine cause memory deﬁcits that are reversed by his-
tamine or the H3 receptor antagonist clobenpropit (Table 4).
Together with the mechanisms described for the modulation
of the septohippocampal pathway [102], histamine seems to
locally regulate ACh release in the hippocampus.
The hippocampus is also required for learning aversive
tasks like inhibitory avoidance and contextual fear condi-
tioning [10, 152]. There is a possible anatomical dissociation
within this region regarding the eﬀects of histamine on
aversive tasks, since in the dorsal hippocampus histamine
seems to facilitate both fear conditioning and passive avoid-
ance through the H2 receptor, while in the ventral area, it
has inhibitory eﬀects on active avoidance through the H110 Neural Plasticity
receptor (Table 4). The extent to which the methodological
peculiarities of each aversive paradigm play a role in this
dissociation remains unclear. In addition, there is evidence
that the hippocampus has a functional segmentation in its
dorsoventral axis, with spatially distinct molecular domains
and subdomains [150]. This might lead to diﬀerences in
receptor density or downstream signaling pathways that
together could account for the observed results.
Thus, the mechanisms that mediate the eﬀects seen in
this area may result from the interplay of histamine with
cholinergic and other aminergic systems, direct activation
of the glutamatergic system through the NMDA receptor, or
by cellular downstream cascades activated from a particular
receptor, with a possible overall combination of one or more
mechanisms [13, 153] that altogether could account for
discrepancies and diﬀerential involvement of histamine in a
particular memory task.
6.5. Administration of Histamine into the Amygdala and
Memory Performance. The amygdala is a complex mass of
gray matter that comprises multiple and distinct subnu-
clei and is richly connected to nearby cortical areas that
constitute the amygdala circuitry. The amygdala contains
three functional subdivisions, each one having a unique
set of connections with other regions of the brain. The
medial group of subnuclei has extensive connections with
the olfactory bulb and the olfactory cortex. The basolateral
group, which is especially large in humans, has major
connections with the cerebral cortex, especially the orbital
and medial prefrontal cortex. The central and anterior group
of nuclei is characterized by connections with the brainstem
and hypothalamus and with visceral sensory structures, such
as the nucleus of the solitary tract. For more details about the
general organization of the amygdala anatomy circuitry, see
[157].
Previous studies have clearly identiﬁed the amygdala as
a key brain structure for acquisition and storage of several
memory types, ﬁrst among them, fear memory. Classical
fear conditioning is a powerful behavioral paradigm that has
been widely studied in amygdala nuclei and mainly in the
basolateral amygdala nucleus (BLA), which have been shown
to participate in the learning and memory consolidation
mechanism [158]. These ﬁndings are consistently supported
by a large number of studies using diﬀerent experimental
paradigms and measures of aversive memory [158, 159]. In
addition, the amygdala also modulates fear-related learning
in the other brain structures, such as the cortex and the
hippocampus [160].
The studies that investigate the modulatory eﬀects of his-
tamine in the BLA are summarized in Table 5.E l e c t r o p h y s i -
ological studies in rat brain slices revealed that histamine can
have bidirectional eﬀects on excitatory synaptic transmission
in BLA depending on the blockage of H3 receptors: the
excitatory postsynaptic potential was depressed in the pres-
ence of histamine alone but increased when the H3 receptor
antagonist thioperamide was added to the preparation [161].
Behavioral models, however, are better suited to study such
eﬀects, since the slice preparation lacks aﬀerent and eﬀerent
projections. Fewbehavioralstudieshaveevaluatedtheroleof
histamine in amygdala.
Evidence using the fear conditioning task with pharma-
cological agonists/antagonists showed that blockage of the
H3 receptors has inhibitory actions, while their activation
improves the expression of fear memory. It has been shown
that the modulation of ACh release in amygdala through the
H3 receptor participates in this modulation, since rats that
received the infusion of H3 receptor antagonists in the BLA
at similar concentrations to those that aﬀected fear memory
had a signiﬁcant reduction in the spontaneous release of
ACh [154]. New approaches using transgenic models agree
with the inhibitory role for histamine in fear memory, since
the lack of H1 and H2 receptors improves memory for this
task, and mice with reduced levels of histamine due to lack
of histamine decarboxylase also have improved performance
although the inactivation was not restricted to the BLA
(Table 3). Along with pharmacological data, this suggests
that these inhibitory eﬀects might also be mediated by the
H1 and H2 receptors.
7. Conclusion
Together, these studies suggest that the manipulation of
the central histaminergic system aﬀects behavioral responses
during several learning and memory processes. However, the
results are often contradictory and do not establish whether
the overall action of histamine on the memory system is
either facilitatory or inhibitory. Methodological issues, such
as time and the methods used in the administration of the
compounds under scrutiny as well as the parameters related
to the behavioral task under evaluation need to be taken
into consideration. Furthermore, in view of the opposite
eﬀects that the activation of the diﬀerent histamine-receptor
subtypes has on memory due to the variability of cellular
action, the ﬁnal course of action of histamine in a network
is not predictable.
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